Autonomix Medical, Inc. is a medical device company focused on advancing technologies to develop how diseases involving the nervous system are diagnosed and treated. The Company’s first-in-class platform system technology includes a catheter-based microchip sensing array that may have the ability to detect and differentiate neural signals with greater sensitivity. It is developing its technology for pancreatic cancer and pancreatitis, conditions that can cause debilitating pain and need an effective solution. Its technology constitutes a platform to address dozens of potential indications, including cardiology, hypertension and chronic pain management, across a wide disease spectrum. Its development efforts are divided into two parts: diagnostic sensing and therapeutic radiofrequency ablation. The Company is developing Autonomix system, which is primarily catheter-based, meaning that its sensing equipment is delivered to its targeted location via a lumen within the body.
公司代碼AMIX
公司名稱Autonomix Medical Inc
上市日期Jan 29, 2024
CEOHauser (Bradley)
員工數量8
證券類型Ordinary Share
年結日Jan 29
公司地址21 Waterway Ave, Suite 300
城市THE WOODLANDS
上市交易所NASDAQ OMX - NASDAQ BASIC
國家United States of America
郵編77380
電話18322777816
網址https://autonomix.com/
公司代碼AMIX
上市日期Jan 29, 2024
CEOHauser (Bradley)